{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:37:51Z","timestamp":1790386671147,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Natural Sciences and Engineering Research Council (NSERC) of Canada","award":["386633-2011"],"award-info":[{"award-number":["386633-2011"]}]},{"name":"European Unio","award":["01GM1408B"],"award-info":[{"award-number":["01GM1408B"]}]},{"name":"Interdisciplinary Center","award":["1970-0-0"],"award-info":[{"award-number":["1970-0-0"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.bbrc.2015.07.112","type":"journal-article","created":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T10:35:05Z","timestamp":1437906905000},"page":"35-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Lack of enzyme activity in GBA2 mutants associated with hereditary spastic paraplegia\/cerebellar ataxia (SPG46)"],"prefix":"10.1016","volume":"465","author":[{"given":"Saki","family":"Sultana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Reichbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sch\u00fcle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Mochel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthis","family":"Synofzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarnoud C.","family":"van der Spoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2015.07.112_bib1","series-title":"Glycolipids: Animal, Encyclopedia of Life Sciences","author":"Hakomori","year":"2001"},{"key":"10.1016\/j.bbrc.2015.07.112_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1083\/jcb.200704091","article-title":"Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis","volume":"179","author":"Halter","year":"2007","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.bbrc.2015.07.112_bib3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bbamcr.2008.09.020","article-title":"Principles of lysosomal membrane degradation: cellular topology and biochemistry of lysosomal lipid degradation","volume":"1793","author":"Schulze","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2015.07.112_bib4","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1172\/JCI29224","article-title":"Mutation of beta-glucosidase 2 causes glycolipid storage disease and impaired male fertility","volume":"116","author":"Yildiz","year":"2006","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.bbrc.2015.07.112_bib5","doi-asserted-by":"crossref","first-page":"30889","DOI":"10.1074\/jbc.M700832200","article-title":"Klotho-related protein is a novel cytosolic neutral beta-glycosylceramidase","volume":"282","author":"Hayashi","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.07.112_bib6","series-title":"The Metabolic and Molecular Bases of Inherited Disease","article-title":"Gaucher disease","author":"Grabowski","year":"2000"},{"key":"10.1016\/j.bbrc.2015.07.112_bib7","first-page":"CD010324","article-title":"Enzyme replacement and substrate reduction therapy for Gaucher disease","volume":"3","author":"Shemesh","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbrc.2015.07.112_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1185\/03007990802576518","article-title":"Goal-oriented therapy with miglustat in Gaucher disease","volume":"25","author":"Pastores","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bbrc.2015.07.112_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1651-2227.2008.00656.x","article-title":"Substrate reduction therapy","volume":"97","author":"Platt","year":"2008","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.bbrc.2015.07.112_bib10","first-page":"373","article-title":"Mutations in CYP2U1, DDHD2 and GBA2 genes are rare causes of complicated forms of hereditary spastic paraparesis","volume":"261","author":"Citterio","year":"2013","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.bbrc.2015.07.112_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajhg.2012.11.021","article-title":"Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia","volume":"92","author":"Martin","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2015.07.112_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ajhg.2012.12.012","article-title":"Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with spasticity","volume":"92","author":"Hammer","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2015.07.112_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/ahg.12045","article-title":"A\u00a0novel GBA2 gene missense mutation in spastic ataxia","volume":"78","author":"Votsi","year":"2014","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.bbrc.2015.07.112_bib14","doi-asserted-by":"crossref","first-page":"26052","DOI":"10.1074\/jbc.M113.463562","article-title":"beta-Glucosidase 2 (GBA2) activity and imino sugar pharmacology","volume":"288","author":"Ridley","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.07.112_bib15","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1073\/pnas.1400768111","article-title":"Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease","volume":"111","author":"Mistry","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2015.07.112_bib16","doi-asserted-by":"crossref","first-page":"e1005063","DOI":"10.1371\/journal.pgen.1005063","article-title":"Accumulation of glucosylceramide in the absence of the beta-glucosidase GBA2 alters cytoskeletal dynamics","volume":"11","author":"Raju","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbrc.2015.07.112_bib17","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1478-3231.2012.02841.x","article-title":"Beta-glucosidase 2 knockout mice with increased glucosylceramide show impaired liver regeneration","volume":"32","author":"Gonzalez-Carmona","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.bbrc.2015.07.112_bib18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0006-2952(99)00384-6","article-title":"N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in\u00a0vitro and in\u00a0vivo","volume":"59","author":"Andersson","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2015.07.112_bib19","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1074\/jbc.M112.414714","article-title":"The non-lysosomal beta-glucosidase GBA2 is a non-integral membrane-associated protein at the endoplasmic reticulum (ER) and Golgi","volume":"288","author":"Korschen","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.07.112_bib20","doi-asserted-by":"crossref","first-page":"26522","DOI":"10.1074\/jbc.273.41.26522","article-title":"Generation of specific deoxynojirimycin-type inhibitors of the non-lysosomal glucosylceramidase","volume":"273","author":"Overkleeft","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.07.112_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7827-5-1","article-title":"The sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study","volume":"5","author":"Bone","year":"2007","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.bbrc.2015.07.112_bib22","doi-asserted-by":"crossref","first-page":"17173","DOI":"10.1073\/pnas.262586099","article-title":"Reversible infertility in male mice following oral administration of alkylated imino sugars: a non-hormonal approach to male contraception","volume":"99","author":"van der Spoel","year":"2002","journal-title":"PNAS"},{"key":"10.1016\/j.bbrc.2015.07.112_bib23","doi-asserted-by":"crossref","first-page":"32655","DOI":"10.1074\/jbc.M702387200","article-title":"Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis","volume":"282","author":"Walden","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.07.112_bib24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bcmd.2013.04.005","article-title":"Miglustat therapy in type 1 Gaucher disease: clinical and safety outcomes in a multicenter retrospective cohort study","volume":"51","author":"Kuter","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bbrc.2015.07.112_bib25","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1098\/rstb.2003.1266","article-title":"The fate and function of glycosphingolipid glucosylceramide","volume":"358","author":"van Meer","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15303429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15303429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T12:52:15Z","timestamp":1532004735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X15303429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0006291X15303429"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.07.112","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of enzyme activity in GBA2 mutants associated with hereditary spastic paraplegia\/cerebellar ataxia (SPG46)","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.07.112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}